Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women

Diabetes Care

Volumn 37, Issue 3, 2014, Pages 725-733

  Appiah, Duke ^a   Winters, Stephen J ^b   Hornung, Carlton A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HYSTERECTOMY; LIFESPAN; MAJOR CLINICAL STUDY; MENARCHE; OVARIECTOMY; POSTMENOPAUSE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; SURGICAL RISK; WAIST CIRCUMFERENCE; ADVERSE EFFECTS; EPIDEMIOLOGY; MIDDLE AGED; PHYSIOLOGY; PREMENOPAUSE; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; DIABETES MELLITUS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; OVARIECTOMY; POSTMENOPAUSE; PREMENOPAUSE;

EID: 84896731556     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1986     Document Type: Article

References (40)

1. Brand JS, van der Schouw YT, Onland-Moret NC, et al.; InterAct Consortium. Age at menopause, reproductive life span, and type 2 diabetes risk: results fromthe EPIC-InterAct study. Diabetes Care 2013;36:1012-1019
2. Kim C. Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women. Womens Health (Lond Engl) 2012;8:155-167
3. American Congress of Obstetricians and Gynecologists. 2011 Women's Health: Stats and Facts. 2011:33-35
4. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411
5. Wu SI, Chou P, Tsai ST. The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 2001;54:117-120
6. Kim C, Edelstein SL, Crandall JP, et al.; Diabetes Prevention Program Research Group. Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause 2011;18:857-868
7. Mishra GD, Carrigan G, Brown WJ, Barnett AG, Dobson AJ. Short-term weight change and the incidence of diabetes in midlife: results from the Australian Longitudinal Study on Women's Health. Diabetes Care 2007;30:1418-1424
8. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006;295: 1288-1299
9. Bonds DE, Lasser N, Qi L, et al. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 2006;49: 459-468
10. Bailey CJ, Ahmed-Sorour H. Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion. Diabetologia 1980;19:475-481
11. Kumagai S, Holmang A, Bjorntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand 1993;149:91-97
12. Campbell SE, Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab 2002;282: E1139-E1146
13. Pirimoglu ZM, Arslan C, Buyukbayrak EE, et al. Glucose tolerance of premenopausal women after menopause due to surgical removal of ovaries. Climacteric 2011;14: 453-457
14. Rincon J, Holmang A, Wahlstrom EO, et al. Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 1996;45:615-621
15. Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008;198:34.e1-34.e7
16. Cox CS, Mussolino ME, Rothwell ST, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1992. Vital Health Stat 1 1997;1-231
17. Miller HW. Plan and operation of the health and nutrition examination survey. United Statesd1971-1973. Vital Health Stat 1 ;1-46
18. World Health Organization. Research on the menopause in the 1990s. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser 1996;866:1-107
19. Bozeman SR, Hoaglin DC, Burton TM, Pashos CL, Ben-Joseph RH, Hollenbeak CS. Predicting waist circumference from body mass index. BMC Med Res Methodol 2012; 12:115
20. Fang J, Wylie-Rosett J, Alderman MH. Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992. Am J Hypertens 2005;18:751-758
21. Korn EL, Graubard BI, Midthune D. Time-toevent analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80
22. Lamarca R, Alonso J, G'omez G, Munoz A. Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. J Gerontol A Biol Sci Med Sci 1998;53:M337-M343
23. Ingram DD, Makuc DM. Statistical issues in analyzing the NHANES I Epidemiologic Followup Study. Series 2: data evaluation and methods research. Vital Health Stat 2 ;1-30
24. Lipton RB, Liao Y, Cao G, Cooper RS, McGee D. Determinants of incident noninsulin-dependent diabetes mellitus among blacks and whites in a national sample. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1993;138:826-839
25. Howard BV, Kuller L, Langer R, et al.; Women's Health Initiative. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation 2005;111: 1462-1470
26. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective populationbased study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7: 375-389
27. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, vonMuhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85:645-651
28. Gonźalez C, Alonso A, D́iaz F, Patterson AM. Dose-and time-dependent effects of 17beta-oestradiol on insulin sensitivity in insulin-dependent tissues of rat: implications of IRS-1. J Endocrinol 2003; 176:367-379
29. Dørum A, Tonstad S, Liavaag AH, Michelsen TM, Hildrum B, Dahl AA. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecol Oncol 2008;109:377-383
30. Michelsen TM, Pripp AH, Tonstad S, Troṕe CG, Dørum A. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer 2009;45:82-89
31. Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994;17:405-411
32. Lemieux S, Lewis GF, Ben-Chetrit A, Steiner G, Greenblatt EM. Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipidlipoprotein levels. J Clin Endocrinol Metab 1999;84:4278-4282
33. Chiavaroli V, Liberati M, D'Antonio F, et al. GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome. Eur J Endocrinol 2010;163:55-62
34. Kanaya AM, Herrington D, Vittinghoff E, et al.; Heart and Estrogen/progestin Replacement Study. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003;138:1-9
35. Michelsen TM, Tonstad S, Pripp AH, Troṕe CG, Dørum A. Coronary heart disease risk profile in women who underwent salpingooophorectomy to prevent hereditary breast ovarian cancer. Int J Gynecol Cancer 2010; 20:233-239
36. Di Donato P, Giulini NA, Bacchi Modena A, et al.; Gruppo di Studio Progetto Menopausa Italia. Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. Climacteric 2005;8:287-293
37. Luborsky JL, Meyer P, Sowers MF, Gold EB, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod 2003; 18:199-206
38. Malacara JM, Huerta R, Rivera B, Esparza S, Fajardo ME. Menopause in normal and uncomplicated NIDDM women: physical and emotional symptoms and hormone profile. Maturitas 1997;28:35-45
39. Phipps AI, Buist DS. Validation of selfreported history of hysterectomy and oophorectomy among women in an integrated group practice setting. Menopause 2009;16:576-581
40. Plusquin C, Fastrez M, Vandromme J, Rozenberg S. Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition. Maturitas 2012;73:164-166